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objective. The risk of carrying methicillin-resistant Staphylococcus aureus (MRSA) is higher among nursing home (NH) residents than in
the general population. However, control strategies are not clearly deﬁned in this setting. In this study, we compared the impact of standard
precautions either alone (control) or combined with screening of residents and decolonization of carriers (intervention) to control MRSA
in NHs.
design. Cluster randomized controlled trial
setting. NHs of the state of Vaud, Switzerland
participants. Of 157 total NHs in Vaud, 104 (67%) participated in the study.
intervention. Standard precautions were enforced in all participating NHs, and residents underwent MRSA screening at baseline and
12 months thereafter. All carriers identiﬁed in intervention NHs, either at study entry or among newly admitted residents, underwent topical
decolonization combined with environmental disinfection, except in cases of MRSA infection, MRSA bacteriuria, or deep skin ulcers.
results. NHs were randomly allocated to a control group (51 NHs, 2,412 residents) or an intervention group (53 NHs, 2,338 residents).
Characteristics of NHs and residents were similar in both groups. The mean screening rates were 86% (range, 27%–100%) in control NHs and
87% (20%–100%) in intervention NHs. Prevalence of MRSA carriage averaged 8.9% in both control NHs (range, 0%–43%) and intervention
NHs (range, 0%–38%) at baseline, and this rate signiﬁcantly declined to 6.6% in control NHs and to 5.8% in intervention NHs after 12 months.
However, the decline did not differ between groups (P= .66).
conclusion. Universal screening followed by decolonization of carriers did not signiﬁcantly reduce the prevalence of the MRSA carriage
rate at 1 year compared with standard precautions.
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Methicillin-resistant Staphylococcus aureus (MRSA) is an
important cause of morbidity and mortality among elderly
people. MRSA causes difﬁcult-to-treat, invasive infections in as
many as 30%–60% of carriers in the acute care setting and in
~5%–15% of carriers in nursing homes (NHs).1–3 The risk of
carrying MRSA is higher for NH residents than for the general
population due to the higher prevalence of comorbidities,
chronic skin ulcers, and frequent exposure to antibiotics.4,5
Furthermore, lifestyle in NHs may favor cross-transmission
between residents by promoting social activities. Finally, NHs
and acute care settings inﬂuence each other; admissions from
one site to another are frequent, especially when NHs also
provide care for short post-acute stays.6–9
The main strategies forMRSA control and prevention are well
established in acute care facilities.3,10 In contrast, these strategies
remain largely empirical in NHs due to the lack of good scientiﬁc
evidence and a paucity of interventional studies.11 It remains
unclear, therefore, whether measures such as MRSA screening,
contact precautions, and decolonization of carriers are beneﬁcial
enough, from an infection control perspective, to justify their
costs, the related burden on NH residents and staff, as well as the
negative impact on residents’ social activities.12,13
Recommendations regarding MRSA in NHs are therefore
often based on expert opinions and vary between countries. In
the Netherlands and some Canadian provinces, MRSA carriers
are placed in single rooms but are not isolated, and contact
precautions are advised for nursing activities only.14,15 Some
US states recommend systematic decolonization along with
contact precautions,16,17 whereas in Belgium, decolonization is
performed along with standard precautions.18
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Prevalence of MRSA carriage in NH residents varies sig-
niﬁcantly across Western countries: 1%–8% in Germany,19,20
5% in Belgium,1 13%–35% in the United States,21,22 5%–22%
in the United Kingdom,7,23 21% in France,24 and 17% in
Spain.25
From 2003 to 2008, three studies investigated the prevalence
of MRSA carriage among residents of the 157 NHs located in
Canton Vaud, Switzerland. MRSA prevalence increased from
4.5% in 2003 to 10% in 2006 (range, 0%–39%) and up to 12%
in 2008 (range, 0%–60%). Although application of standard
precautions is the recommended policy for MRSA control in
NHs, heterogeneous strategies are still used across the canton.
To further determine the most appropriate MRSA control
strategy in NH settings, we compared the impact of 2
approaches on the 1-year prevalence of MRSA carriage among
NH residents in the canton. Speciﬁcally, standard precautions,
as recommended for all patients in any healthcare setting,10,26
were compared with a more aggressive strategy that combined
the same standard precautions with systematic screening of all
residents and decolonization of carriers and disinfection of
their environment.
methods
Study Design, Setting, and Participants
This prospective cluster randomized controlled study took
place from June 2010 to December 2011 in Canton Vaud, a
state with 0.8 million inhabitants in western Switzerland. In
2011, the state had 53 NH beds per 1,000 inhabitants aged 65
years and over, distributed among 157 NHs with 7–153 beds
(mean, 43 beds per NH).27
NHs mostly provide long-term care for older people unable
to remain at home because of permanent physical and/or
mental disability. Although some NHs specialize in the care of
residents with severe dementia or chronic psychiatric condi-
tions (psychogeriatric NHs), most NHs also host residents
with mild and moderate dementia. As Canton Vaud
encourages home care services, the average length of a resi-
dent’s stay in an NH was only 2.4± 1.1 years in 2011.27
All 157 NHs located in Canton Vaud were invited to parti-
cipate. The study was approved by the research ethics com-
mittee of Canton Vaud, Switzerland (Protocol 96/10). It was
registered in ClinicalTrials.gov database (NCT01138462).
Randomization and Intervention
NHs were used as unit of randomization. Using a computer-
generated code, participating NHs were randomly allocated to
either intervention (ie, universal MRSA screening and topical
decolonization of carriers and disinfection of their environ-
ment along with standard precautions) or control (ie, standard
precautions alone) groups.
In each participating NH, oral informed consent for the
screening of MRSA carriage was requested from residents or
their legal representatives when appropriate. Because most
NHs also provide respite care, residents for whom the planned
length of stay was <3 weeks were excluded from screening, as
were those in a terminal condition (ie, life expectancy
<1 week). Residents in intervention NHs were considered
ineligible for decolonization if they had hypersensitivity to ≥1
of the substances used for decolonization. In addition, NH
residents were considered temporarily ineligible if they were
infected with MRSA or if they had an MRSA bacteriuria or a
stage 4 chronic ulcer (according to NPUAP staging28), until
resolution of condition.
MRSA carriage screening. All residents who gave their oral
informed consent underwent screening for MRSA carriage at
study entry and 12 months thereafter. Baseline and follow-up
screening campaigns were each completed over a 6-month
period and over a single day in each participating NH.
Additionally, all newly admitted or readmitted (usually after an
acute-care stay) residents over the 12-month study period
underwent MRSA screening.
Screening was performed by study nurses who were not
employed by the NH. They used polyester ﬁber-tipped swabs
to collect samples from nostrils, groin, and ulcers (if applic-
able). In addition, they collected urine for culture from resi-
dents equipped with a permanent urinary catheter. All samples
were transported to the laboratory on the same day and were
processed within 24 hours, as previously described.29
Intervention. All healthcare workers from participating
NHs (in both control and intervention groups) participated in
training sessions on the concept and practice of standard
precautions10 that should be applied to all residents,
independent of their MRSA status. Training sessions were
delivered by 1 dedicated study nurse in all participating NHs.
In addition, teaching material such as DVD and ﬂyers on
standard precautions were distributed. Screening results were
kept blind in the NHs allocated to the control group to avoid
differences in nursing care.
In intervention NHs, MRSA-positive residents identiﬁed at
study entry or upon admission during the study period
underwent a topical decolonization combined with a disin-
fection of their environment. For this purpose, healthcare
workers in intervention NHs received additional speciﬁc
training and teaching material about the decolonization pro-
tocol and environmental disinfection.
Decolonization protocol. The topical decolonization
protocol was conducted over 5 consecutive days, in
association with environmental disinfection (Table 1).3,13,30
Decolonization was considered successful if 2 MRSA-negative
results were obtained from screenings performed 7 days apart
and at least 7 days after the completion of the protocol.
Decolonization was repeated once in case of failure.
Data collection and outcome. At baseline, study nurses
collected data on the following NH characteristics: mission
(psychogeriatric or not), number of beds, proportion of single
rooms, number of toilets, number of healthcare workers per
resident, and average daily nursing workload.
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For each screened resident, data was collected on age, gender,
NH admission date and provenance (home, hospital, or another
NH), and functional status.31 Furthermore, the following risk
factors for MRSA carriage were collected: previously docu-
mented MRSA carriage, hospital admissions during the previous
year, chronic pressure ulcers, invasive medical devices, diabetes
mellitus, and antibiotic therapy during the previous 30 days. A
diagnosis of diabetes mellitus was only considered if the resident
was being treated with insulin.
Study outcome was the change in prevalence of MRSA
carriage among residents in each NH at the end of the 12-month
study period.
Statistical Analysis
Two main approaches have been proposed to analyze data from
a cluster randomized design.32,33 The traditional approach
considers the cluster as the unit of analysis and calculates sum-
mary statistics in each cluster (in our case in each NH). As
recalled in Campbell et al,32 “because each cluster then provides
only one single data point, the data can be considered to be
independent, allowing standard statistical tests to be used.” This
approach has the merit of simplicity34 as well as consistency with
our unit of randomization.35 Thus, we calculated the 1-year
change in MRSA prevalence for each NH, then we compared
intervention and control groups using a Mann-Whitney test.
The signiﬁcance of the change in prevalence between baseline
and after 12 months was also assessed separately within each NH
group using a Wilcoxon signed rank test. Alternatively, we ana-
lyzed data at the individual level, considering the individual as
the unit of analysis and attempting to adequately model the
dependencies induced by the cluster effect using a generalized
linear mixed model. We use a post-hoc analysis because we had
to restrict our attention to those “permanent” residents who
table 1. Topical Decolonization Protocol and Environmental Disinfection Used in the Study
First Choice Alternative
Topical decolonization
Nostrils Mupirocin ointmenta t.i.d. for 5 d, using
a cotton stalk
Bacitracine/neomycin ointmentb
Pharynx Chlorhexidine 0.11%c oral rinsing for
15 s, b.i.d. for 5 d
Octenidine oral solutiond
Skin Daily shower with 4% chlorhexidinee
soap for 5 d
Octenidine soapf
If shower not feasible: cetylpridinium chlorideg–
impregnated wipes
Hair Shampooing with 4% chlorhexidinee
soap on days 1 and 5
Octenidine soapf
If shower not feasible: cetylpridinium chlorideg–
impregnated head caps
Dental prosthesis Chlorhexidine 0.2%h during 30 min q.d. Octenidine oral solutiond
Stage 2 or 3 ulcers colonized by MRSA Povidone-iodinei q.d. or chlorhexidinej Octenidinek
Environment disinfection
Clothes Daily change for 5 d
Linen Change on days 1 and 5
Bed Daily disinfection with 70% alcohol
Bedside table
Phone
Walking aid
Wheelchair armrests
Television remote control
NOTE. MRSA, methicillin-resistant Staphylococcus aureus; q.d.= once per day (quaque die); b.i.d= twice per day (bis in die); t.i.d.= three times
per day (ter in die).
aBactroban®; GlaxoSmithKline, Münchenbuchsee, Switzerland.
bNeotracin®; Omnivision, Neuhausen, Switzerland.
cCollunovar®; Thepenier Pharma, St Langis Les Mortagne, France.
dOctenidol® oral solution; Schülke, Zurich, Switzerland.
eLifoscrub®; Braun Medical, Sempach, Switzerland; or Hibiscrub®; Streuli Pharma, Uznach, Switzerland.
fOctenisan® soap; Schülke, Zurich, Switzerland.
gBedbath Oasis®; Gompels Healthcare, Melksham Wiltshire, UK.
hCorsodyl®; GlaxoSmithKline, Münchenbuchsee, Switzerland.
iBetadine®; Mundipharma, Basel, Switzerland.
jMerfen®; Novartis, Basel, Switzerland; or Hibidil®; Cito Pharma, Uster, Switzerland.
kOcteniderm®; Schülke, Zurich, Switzerland.
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remained in their NH throughout the study. P< .05 was con-
sidered statistically signiﬁcant. We used STATA 12.0 software
(StataCorp, College Station, Texas, USA) and the R free statistical
software (version 2.5.1).
The sample size was imposed by the pragmatic design and
the public funding of the study, ie, by the existing number of
NHs in the state where it took place. Based on results from
local previous surveys, this study hypothesized that an initial
MRSA carriage prevalence of 12% in the control NHs would
increase by 20% (ie, from 12% to 14%) after 12 months. Using
the conservative estimate of a 30% decolonization success rate
in intervention NHs, followed by the same 20% increase in
MRSA prevalence as in controls, the power of the study would
be 0.51. This would ensure a statistically signiﬁcant result in
cases where the observed effects were equal to or larger
than the hypothetical effects.36 The power would increase to
>0.99 if we assumed a 70% decolonization success rate, as
observed in studies involving healthcare workers or healthy
volunteers.37
results
Of the 157 NHs in Canton Vaud, 105 (67%) registered to
participate in the study. As 1 NH allocated to the control group
withdrew its agreement during the course of the study, the
ﬁnal analysis included 51 NHs (corresponding to 2,412
residents) in the control group and 53 NHs (2,338 residents) in
the intervention group (Figure 1).
There were no signiﬁcant differences in baseline character-
istics between the 2 NH groups (Table 2). The proportion of
residents who accepted and underwent MRSA screening was
heterogeneous, ranging from 27% to 100% (mean, 86%) in
control NHs and from 20% to 100% (mean, 87%) in inter-
vention NHs. At baseline, the mean prevalence of MRSA
carriage was 8.9% in both groups, ranging from 0% to 43% in
control NHs and from 0% to 39% in intervention NHs. This
baseline prevalence was positively correlated to NH size
(Spearman coefﬁcient, 0.31; P= .001) and was negatively
correlated to the ratio of healthcare workers per resident, and
Refused to participate: 42
All NHs in the region
(N=157 NHs)
Randomized
(105 NHs)
Intervention
(54 NHs)
Control
(51 NHs)
Universal MRSA screening at
study entry
Continuous MRSA screening
of new or re-admissions
during study period
Universal MRSA screening at
study entry
Continuous MRSA screening
of new or re-admissions
during study period
Excluded: 1
(no final screening)
Decolonization of MRSA
carriers
Universal MRSA screening at
study end
Universal MRSA screening at
study end
53 NHs analyzed 51 NHs analyzed
ﬁgure 1. Study ﬂow diagram. MRSA, methicillin-resistant Staphylococcus aureus; NH: nursing home.
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(Spearman coefﬁcient, −0.21; P= .03). MRSA strains were all
susceptible to mupironcin. No invasive MRSA infections were
observed during the entire study period.
Evolution of the Prevalence of MRSA Carriage in NHs
The proportion of residents available for screening at the end
of the study was 89% in both control and intervention NHs.
The changes in prevalence of MRSA carriage in each NH
belonging to the intervention and control groups are repre-
sented in Figure 2. The mean prevalence decreased sig-
niﬁcantly by 3.0% in the intervention NHs (from 8.9% to
5.8%; P= .003) and by 2.3% in the control NHs (from 8.9% to
6.6%; P= .02). This corresponded to a nonsigniﬁcant 0.7%
decrease attributable to the intervention (P= .66).
Data were then analyzed at the individual level for the
3,790 permanent residents, using a generalized linear mixed
model, with NH random effects to predict the MRSA carriage
of a resident (positive/negative), given his/her baseline
value and his/her group (intervention/control). The odds ratio
of being a MRSA carrier was estimated to be 1.38 higher in the
control group than in the intervention group. However,
this odds ratio was not signiﬁcant (P= .17). Notably, the
baseline prevalence of MRSA for permanent residents was
6.7% in the intervention group, whereas it was 9.1% in the
control group, which warranted an adjustment for the
baseline value.
Several exploratory secondary analyses were performed to
investigate whether changes in MRSA prevalence varied
according to various subgroups of NHs (Table 3). Results of each
exploratory analysis showed a decrease in the mean prevalence
over the 12-month study period in both control and intervention
NHs, except in those NHs with baseline prevalence below the
median value, where there was not much room for improve-
ment. Across the various subgroups, decline inMRSA prevalence
was slightly but consistently more important in the intervention
group than in the control group. However, none of these dif-
ferences achieved statistical signiﬁcance. The largest improve-
ment in the intervention group compared to the control group
were observed among NHs with higher baseline prevalence,
higher proportion of screened residents, lower number of beds,
and lower number of healthcare workers per 100 residents.
discussion
This pragmatic randomized controlled trial was conducted in
104 NHs with >4,700 residents. To our knowledge, it is the
ﬁrst to investigate the impact of universal screening for MRSA
carriage and decolonization of carriers in NHs, combined with
a disinfection of their environment.11 The results of our
study show no signiﬁcant beneﬁt of this strategy on the pre-
valence of carriage compared with the application of standard
precautions. This result is relevant in a ﬁeld in which there is
currently a paucity of evidence.
table 2. Characteristics of Participating Nursing Homes at Baselinea
Control NHs
(n= 51; 2,412 residents), ± SD
Intervention NHs
(n= 53; 2,338 residents), ± SD
No. of beds 47± 30 44± 25
Proportion of single rooms (%) 60± 23 62± 26
No. of toilets per 100 residents 53± 32 51± 27
No. of shower cabins per 100 residents 31± 28 30± 21
No. of healthcare workers per resident 0.59± 0.13 0.56± 0.12
Average daily nursing workload, min 165± 22 167± 22
Age of residents, years 83.4± 5.4 83.7± 8.1b
Proportion of female residents, % 73± 10 72± 12
Proportion of residents with at least 1 risk factor for MRSA carriage, % 27± 9 29± 10
Diabetes, % 5.7± 4.3 6.4± 5.0
Pressure ulcers, % 8.9± 4.8 8.6± 5.4
Urinary catheter or other devices, % 7.5± 6.6 7.7± 5.0
Antibiotics in the previous 30 d, % 11.2± 5.6 14.1± 8.1
Hospital stay in the previous year, % 42.7± 13.5 42.5± 11.6
Average functional status score of residentsc 2.9± 0.6 2.9± 0.8
Proportion of resident screened, % 86.4± 18 87± 17
Prevalence of MRSA carriage among screened residents, % 8.9± 9.0 8.9± 9.3
NOTE. SD, standard deviation; MRSA, methicillin-resistant Staphylococcus aureus; NHs, nursing homes
aFor the 52 non-participating NH (1852 residents), the average number of beds (43± 27) and the average daily nursing workload in minutes
(159± 27) were similar.
bP= .05 compared to control NHs. No other P values were statistically signiﬁcant.
cKatz score,31 ranging from 0 to 6, with higher scores indicating better function.
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Another randomized controlled trial conducted in 32 NHs
in Northern Ireland showed that an infection control program
based solely on a staff education intervention had no effect on
MRSA prevalence.38
The lack of efﬁcacy of universal screening and decoloniza-
tion of carriers in the present study may be largely attributable
to the decrease in prevalence of MRSA carriage measured in
control NHs as well. This unexpected ﬁnding contradicts the
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ﬁgure 2. Evolution of the prevalence of MRSA carriage in nursing homes. Each thin line represents the evolution from baseline to
12-month follow-up of MRSA carriage prevalence in NHs from the control group (left panel) and the intervention group (right panel). The
thick line represents the evolution of the mean prevalence of MRSA carriage in NHs from the control group (left panel) and the intervention
group (right panel). MRSA, methicillin-resistant Staphylococcus aureus. NH, nursing home.
table 3. Comparison of the Mean Changes in MRSA Prevalence Between Control and Intervention Among All Nursing Homes (NHs)
and Among Various Subgroupsa
Mean Change in Prevalence, %
Control NHs Intervention NHs P Valueb
All NHs −2.3 (n= 51) −3.0 (n= 53) .66
Baseline prevalence <7% +0.9 (n= 23) +0.3 (n= 28) .56
Baseline prevalence ≥7% −4.8 (n= 28) −6.8 (n= 25) .38
Proportion of residents screened <92% −1.4 (n= 28) −1.9 (n= 24) .52
Proportion of residents screened ≥92% −3.3 (n= 23) −4.0 (n= 29) .96
No. of beds <38 −3.1 (n= 26) −4.3 (n= 25) .83
No. of beds ≥38 −1.6 (n= 25) −1.9 (n= 28) .54
No. of healthcare workers per 100 residents <0.57 −3.4 (n= 24) −4.7 (n= 28) .38
No. of healthcare workers per 100 residents ≥0.57 −1.2 (n= 27) −1.2 (n= 25) .38
Proportion of single room <57% −2.5 (n= 27) −3.7 (n= 24) .70
Proportion of single room ≥57% −2.0 (n= 24) −2.5 (n= 29) .79
NOTE. MRSA, methicillin-resistant Staphylococcus aureus; NH, nursing home.
aSubgroups of NHs were obtained by dichotomizing each factor (baseline prevalence, proportion of screened residents, number of beds, number
of healthcare workers per 100 residents, proportion of single rooms) according to its median value in the 104 participating NHs.
bP values from Mann-Whitney test.
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upward trend observed in 3 consecutive prevalence surveys
performed prior to this study in 2003, 2006, and 2008. This
result could not be due to an out-of-protocol use of a deco-
lonization regimen because screening results were kept blinded
in this study group. At least 2 hypotheses could be proposed to
explain this downward trend. First, it may result from a
spontaneous evolution of the predominant MRSA clones, as
the evolution of these clones often has a wave-like shape.39
This hypothesis is strengthened by a baseline prevalence that
was lower than expected. This ﬁnding decreased the statistical
power of the study to show an impact of the intervention
because it left less room for improvement, as illustrated by the
null prevalence observed at baseline in several NHs. Interest-
ingly, we found that the baseline prevalence of MRSA carriage
was positively correlated with the size of the NH and negatively
correlated with the healthcare-worker-to-resident ratio, a
ﬁnding that may be relevant to public health authorities
involved in the organization of NHs. Second, an alternative or
complementary hypothesis to explain the decrease in MRSA
prevalence in control NHs may be an enhanced quality of care,
as prior prevalence surveys were likely to have stimulated
efforts toward a better observation of standard precautions.
This trend was further reinforced by the training program
developed in the context of the present study itself.
The study might have shown a more encouraging impact of
screening and decolonization had this strategy been tested in
selected NHs. Indeed, exploratory subgroup analyses suggest a
possible, although not signiﬁcant, beneﬁt in those NHs with the
lowest number of beds, the highest proportion of residents
screened, the highest baseline prevalence of MRSA carriage, and
the lowest number of healthcare workers per 100 residents.
This study suffered from several limitations that may have
contributed to its negative results. One limitation was the
relatively modest power of the study (calculated at 51%). Still,
the intervention’s impact would actually have been statistically
signiﬁcant had the prevalence of MRSA carriage not decreased
in the control NHs. Further limitations stemmed from the
fact that the study was conducted in real-life conditions.
Indeed, screening was less than optimal, ranging from 20% to
100% of the residents from participating NHs. However, an
average participation rate of 87% left most NHs with some
unidentiﬁed MRSA carriers who may have compromised
the intervention’s effects. This limitation, in addition to a
subpopulation of MRSA carriers who were not eligible for
decolonization, may have prevented MRSA transmission from
achieving a level low enough to permit a reduction in the
prevalence of carriage.
However, these limitations induced by the study’s real-life
conditions also allowed us to obtain the most realistic results
possible, and these results will be useful in helping public
health authorities to choose preventive strategies in NH set-
tings. Another strength of this study was its almost complete
reliance on everyday NH resources and staff.
In conclusion, this study found no beneﬁt from universal
screening and decolonization of carriers along with standard
precautions compared with standard precautions alone in
reducing the prevalence of MRSA carriage in NHs. Additional
investigations are needed to determine whether a similar
intervention strategy could be effective under speciﬁc epide-
miological conditions, such as very high prevalence of MRSA
carriage or in case of an outbreak.
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